Hsbc Holdings PLC Purchases New Position in Chemed Corporation $CHE

Key Points

• HSBC Holdings acquired 12,346 Chemed shares during the second quarter, worth approximately $5.7 million, while institutional investors collectively own 95.85% of the stock.
• Chemed reported quarterly EPS of $6.06, beating estimates of $5.60, with revenue rising 8.8% year over year to $673.25 million. The company also raised its quarterly dividend from $0.60 to $0.70 per share.
• Analysts maintain a consensus “Hold” rating with a $530.75 price target; shares recently opened at $523.57, near their 12-month high of $557.00, while insiders have sold more than $3.4 million in stock over the past 90 days.

Hsbc Holdings PLC acquired a new position in Chemed Corporation (NYSE:CHE - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 12,346 shares of the company's stock, valued at approximately $5,729,000. Hsbc Holdings PLC owned approximately 0.09% of Chemed as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Quantbot Technologies LP acquired a new stake in Chemed during the 2nd quarter valued at approximately $1,726,000. TD Asset Management Inc boosted its stake in shares of Chemed by 7.5% during the 4th quarter. TD Asset Management Inc now owns 324,546 shares of the company's stock valued at $138,860,000 after buying an additional 22,715 shares during the last quarter. BNP Paribas Financial Markets boosted its stake in shares of Chemed by 14.5% during the 4th quarter. BNP Paribas Financial Markets now owns 35,024 shares of the company's stock valued at $14,985,000 after buying an additional 4,430 shares during the last quarter. Epoch Investment Partners Inc. grew its position in shares of Chemed by 4.9% during the fourth quarter. Epoch Investment Partners Inc. now owns 322,408 shares of the company's stock worth $137,945,000 after buying an additional 15,133 shares in the last quarter. Finally, C WorldWide Group Holding A S bought a new stake in shares of Chemed in the fourth quarter worth $2,189,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $541.16, for a total transaction of $1,082,320.00. Following the sale, the chief executive officer owned 70,418 shares in the company, valued at $38,107,404.88. This represents a 2.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Patrick P. Grace sold 190 shares of the firm's stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the transaction, the director directly owned 3,533 shares in the company, valued at $1,879,556. This represents a 5.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 6,537 shares of company stock worth $3,406,014 in the last ninety days. Insiders own 3.33% of the company's stock.

Analyst Ratings Changes

Several research firms recently issued reports on CHE. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. Oppenheimer boosted their target price on shares of Chemed from $500.00 to $590.00 and gave the stock an "outperform" rating in a research report on Friday, July 31st. Bank of America restated a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Royal Bank Of Canada increased their price target on shares of Chemed from $436.00 to $548.00 and gave the stock a "sector perform" rating in a research report on Thursday, July 30th. Finally, Wall Street Zen upgraded Chemed from a "hold" rating to a "strong-buy" rating in a research note on Saturday, August 1st. One analyst has rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $530.75.

Chemed Stock Performance

Shares of CHE opened at $523.57 on Friday. The business's fifty day moving average price is $509.45 and its 200 day moving average price is $449.67. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The stock has a market capitalization of $6.84 billion, a PE ratio of 26.30, a price-to-earnings-growth ratio of 1.97 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89.

Chemed (NYSE:CHE - Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. The firm had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The firm's revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $4.27 earnings per share. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts forecast that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Monday, August 17th will be given a dividend of $0.70 per share. The ex-dividend date of this dividend is Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.5%. This is a boost from Chemed's previous quarterly dividend of $0.60. Chemed's payout ratio is currently 14.06%.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source